Literature DB >> 25709077

EFFECT OF THE APOE ε4 ALLELE AND COMBAT EXPOSURE ON PTSD AMONG IRAQ/AFGHANISTAN-ERA VETERANS.

Nathan A Kimbrel1, Michael A Hauser, Melanie Garrett, Allison Ashley-Koch, Yutao Liu, Michelle F Dennis, Rebecca C Klein, Jean C Beckham.   

Abstract

BACKGROUND: The apolipoprotein E (APOE) ε4 allele has been implicated in a range of neuropsychiatric conditions. The present research examined if the ε4 allele of the APOE gene moderated the effect of combat exposure on posttraumatic stress disorder (PTSD) among Iraq/Afghanistan-era veterans.
METHOD: Participants included 765 non-Hispanic White (NHW) and 859 non-Hispanic Black (NHB) Iraq/Afghanistan-era veterans. A structured interview established psychiatric diagnoses. Combat exposure and PTSD symptom severity were assessed via self-report.
RESULTS: The most common lifetime diagnoses were depression (39.2%), PTSD (38.4%), and alcohol dependence (24.38%). After correcting for multiple comparisons, no significant effects were observed on any of the outcomes among the NHW sample; however, within the NHB sample, significant gene × environment (G × E) interactions were observed for lifetime PTSD (P = .0029) and PTSD symptom severity (P = .0009). In each case, the APOE ε4 allele had no effect on the outcomes when combat exposure was low; however, when combat exposure was high, an additive effect was observed such that ε4 homozygotes exposed to high levels of combat reported the highest rates of PTSD (92%) and the worst symptom severity scores on the Davidson Trauma Scale (M = 79.5).
CONCLUSIONS: Although preliminary, these findings suggest that the APOE ε4 allele, in conjunction with exposure to high levels of combat exposure, may increase veterans' risk for developing PTSD.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOE; PTSD; comorbidity; depression; genetic; veteran

Mesh:

Substances:

Year:  2015        PMID: 25709077      PMCID: PMC4697754          DOI: 10.1002/da.22348

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  37 in total

1.  Association of apolipoprotein E polymorphism with outcome after head injury.

Authors:  G M Teasdale; J A Nicoll; G Murray; M Fiddes
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

2.  A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms.

Authors:  W R True; J Rice; S A Eisen; A C Heath; J Goldberg; M J Lyons; J Nowak
Journal:  Arch Gen Psychiatry       Date:  1993-04

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  Neuropsychiatric associations of apolipoprotein E alleles in subjects with combat-related posttraumatic stress disorder.

Authors:  Thomas Freeman; Vincent Roca; Fred Guggenheim; Tim Kimbrell; W S T Griffin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

5.  Assessment of a new self-rating scale for post-traumatic stress disorder.

Authors:  J R Davidson; S W Book; J T Colket; L A Tupler; S Roth; D David; M Hertzberg; T Mellman; J C Beckham; R D Smith; R M Davison; R Katz; M E Feldman
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

Review 6.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

Review 7.  Genetics of posttraumatic stress disorder: Review and recommendations for future studies.

Authors:  Karestan C Koenen
Journal:  J Trauma Stress       Date:  2007-10

8.  TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E.

Authors:  Werner Koch; Angela Ehrenhaft; Korinna Griesser; Arne Pfeufer; Jakob Müller; Albert Schömig; Adnan Kastrati
Journal:  Clin Chem Lab Med       Date:  2002-11       Impact factor: 3.694

9.  Posttraumatic stress disorder in the National Comorbidity Survey.

Authors:  R C Kessler; A Sonnega; E Bromet; M Hughes; C B Nelson
Journal:  Arch Gen Psychiatry       Date:  1995-12

Review 10.  Strategy for investigating interactions between measured genes and measured environments.

Authors:  Terrie E Moffitt; Avshalom Caspi; Michael Rutter
Journal:  Arch Gen Psychiatry       Date:  2005-05
View more
  13 in total

1.  Combat experience and problem drinking in veterans: Exploring the roles of PTSD, coping motives, and perceived stigma.

Authors:  Stephen M Miller; Eric R Pedersen; Grant N Marshall
Journal:  Addict Behav       Date:  2016-11-15       Impact factor: 3.913

2.  Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species.

Authors:  Laura E Villasana; Sydney Weber; Tunde Akinyeke; Jacob Raber
Journal:  J Neurochem       Date:  2016-08-19       Impact factor: 5.372

3.  Apolipoprotein E gene polymorphism, trauma burden, and posttraumatic stress symptoms in U.S. military veterans: Results from the National Health and Resilience in Veterans Study.

Authors:  Natalie P Mota; Shizhong Han; Ilan Harpaz-Rotem; Paul Maruff; John H Krystal; Steven M Southwick; Joel Gelernter; Robert H Pietrzak
Journal:  Depress Anxiety       Date:  2017-11-24       Impact factor: 6.505

4.  Effect of genetic variation in the nicotinic receptor genes on risk for posttraumatic stress disorder.

Authors:  Nathan A Kimbrel; Melanie E Garrett; Michelle F Dennis; Yutao Liu; Ilyas Patanam; Va Mid-Atlantic Mirecc Workgroup; Allison E Ashley-Koch; Michael A Hauser; Jean C Beckham
Journal:  Psychiatry Res       Date:  2015-07-08       Impact factor: 3.222

5.  Apolipoprotein E ε4 Genotype Is Associated with Elevated Psychiatric Distress in Veterans with a History of Mild to Moderate Traumatic Brain Injury.

Authors:  Victoria C Merritt; Alexandra L Clark; Scott F Sorg; Nicole D Evangelista; Madeleine Werhane; Mark W Bondi; Dawn M Schiehser; Lisa Delano-Wood
Journal:  J Neurotrauma       Date:  2018-06-07       Impact factor: 5.269

6.  The Post-Deployment Mental Health (PDMH) study and repository: A multi-site study of US Afghanistan and Iraq era veterans.

Authors:  Mira Brancu; H Ryan Wagner; Rajendra A Morey; Jean C Beckham; Patrick S Calhoun; Larry A Tupler; Christine E Marx; Katherine H Taber; Robin A Hurley; Jared Rowland; Scott D McDonald; Jeffrey M Hoerle; Scott D Moore; Harold S Kudler; Richard D Weiner; John A Fairbank
Journal:  Int J Methods Psychiatr Res       Date:  2017-06-27       Impact factor: 4.035

7.  A genome-wide association study of suicide attempts and suicidal ideation in U.S. military veterans.

Authors:  Nathan A Kimbrel; Melanie E Garrett; Michelle F Dennis; Michael A Hauser; Allison E Ashley-Koch; Jean C Beckham
Journal:  Psychiatry Res       Date:  2018-07-17       Impact factor: 3.222

8.  Gene-Environment Interplay in Physical, Psychological, and Cognitive Domains in Mid to Late Adulthood: Is APOE a Variability Gene?

Authors:  Chandra A Reynolds; Margaret Gatz; Kaare Christensen; Lene Christiansen; Anna K Dahl Aslan; Jaakko Kaprio; Tellervo Korhonen; William S Kremen; Robert Krueger; Matt McGue; Jenae M Neiderhiser; Nancy L Pedersen
Journal:  Behav Genet       Date:  2015-11-04       Impact factor: 2.805

9.  An examination of the association between 5-HTTLPR, combat exposure, and PTSD diagnosis among U.S. veterans.

Authors:  Yutao Liu; Melanie E Garrett; Michelle F Dennis; Kimberly T Green; Allison E Ashley-Koch; Michael A Hauser; Jean C Beckham; Nathan A Kimbrel
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

10.  Post-Traumatic Stress Disorder Delineating the Progression and Underlying Mechanisms Following Blast Traumatic Brain Injury.

Authors:  Brandon Lucke Wold; Richard Nolan; Divine Nwafor; Linda Nguyen; Cletus Cheyuo; Ryan Turner; Charles Rosen; Robert Marsh
Journal:  J Neurosci Neuropharmacol       Date:  2018-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.